GNH USA

Europe — EMA

Feiba

Feiba (Factor VIII Inhibitor Bypassing Fraction) is a medication used to manage bleeding episodes in patients with hemophilia who have developed inhibitors. Thi

Factor Viii Inhibitor Bypassing Fraction

Request sourcing

1
Pack/s

What is Factor Viii Inhibitor Bypassing Fraction?

Feiba (Factor VIII Inhibitor Bypassing Fraction) is a medication used to manage bleeding episodes in patients with hemophilia who have developed inhibitors. This intravenous treatment helps to bypass the need for Factor VIII, providing essential clotting support. Learn more about Feiba's uses and effects.

What is Factor Viii Inhibitor Bypassing Fraction used for?

Feiba is primarily used to control bleeding in patients with hemophilia A or B who have developed inhibitors to Factor VIII or IX. These inhibitors can make standard treatments ineffective, so Feiba is often used as an alternative. It is commonly administered intravenously to help manage bleeding episodes and provide necessary clotting support. Patients and healthcare providers often ask, 'What is Feiba used for?' and the answer lies in its ability to bypass the need for Factor VIII, making it a crucial treatment for those with hemophilia and inhibitors.

What are the side effects of Factor Viii Inhibitor Bypassing Fraction?

Feiba works by providing clotting factors that help to stop bleeding in patients with hemophilia who have developed inhibitors. Common effects may include localized reactions at the injection site, such as redness or swelling. Some patients may also experience mild to moderate side effects like fever or nausea. It is important to monitor for any adverse reactions and consult a healthcare provider if they occur.

What precautions apply to Factor Viii Inhibitor Bypassing Fraction?

Feiba should be handled with care, following proper storage and administration guidelines. It is crucial to use sterile techniques when preparing and administering the medication to prevent infections. Patients should be monitored for any signs of allergic reactions or other adverse effects. Always follow the instructions provided by a healthcare professional to ensure safe and effective use.

What does Factor Viii Inhibitor Bypassing Fraction interact with?

Feiba may interact with other medications, so it is important to inform your healthcare provider about all the drugs you are taking. Certain medications, such as anticoagulants, may affect the clotting process and could interact with Feiba. Additionally, patients should avoid activities that increase the risk of bleeding, such as contact sports, while using this medication.

Frequently asked questions

What is Feiba used for?+
Feiba is used to manage bleeding episodes in patients with hemophilia who have developed inhibitors to Factor VIII or IX.
How is Feiba administered?+
Feiba is administered intravenously, typically by a healthcare professional, to provide clotting support.
What are the common side effects of Feiba?+
Common side effects may include localized reactions at the injection site, fever, or nausea.
Can Feiba be used with other medications?+
Feiba may interact with other medications, so it is important to consult a healthcare provider before combining treatments.
How should Feiba be stored?+
Feiba should be stored according to the manufacturer's instructions, typically in a refrigerator, to maintain its effectiveness.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Factor Viii Inhibitor Bypassing Fraction
Route
Intravenous Use
Manufacturer
Takeda Gmbh
Origin
EU

Related products